[Diabetes-talk] Latest Trends in Care

[William and Bernadette Jacobs]

So how much of this is accessible by a blind guy?  any idea?  Hopefully I'm 
wrong in my suspicions?

Bern
----- Original Message ----- 
From: "Doug Billiar" <natemaster at atmc.net>
To: "'Diabetes Talk for the Blind'" <diabetes-talk at nfbnet.org>
Sent: Wednesday, January 18, 2012 2:18 PM
Subject: [Diabetes-talk] Latest Trends in Care


>
>
>
> 1. Echo Therapeutics - The Symphony System. It is a non-needle,
> non-invasive, wireless transdermal continuous glucose monitoring system.
> Until now, the
> CGM systems have required a needle or sensor to be placed under the skin 
> and
> changed anywhere between 3-7 days; you are still required to use finger
> sticks
> for calibration of the CGM. The CGM records blood sugar levels throughout
> the day and night; it helps track trends showing dips and spikes of the
> blood
> sugar. The Symphony System uses a biosensor without the need to prick the
> skin since it is transdermal [it is an adhesive patch placed on the skin].
> F.D.A.
> approval is expected in 2013 and is showing strong successes in clinical
> trials. Testing is being done on hospitalized critical care patients who
> require
> multiple finger sticks daily; it is well documented that blood sugar 
> control
> is imperative during acute illness and trends need to be monitored. 
> Studies
> are also being conducted on out-patients with diabetes. The transdermal
> patch would require changing every 24 hours. The needleless system
> technology is
> a benefit for those who dread needle placement as well as having the 
> ability
> to lower the risk of infection especially in the hospital critical care
> arena.
> 2. Novo-Nordisk - Degludec. Although there are basal insulins such as 
> Lantus
> and Levemir already available, Novo Nordisk is working on Degludec and
> DegludecPlus
> as acceptable long acting choices. It is longer acting and improves blood
> glucose levels with a lower risk of hypoglycemia especially during the
> nighttime;
> it will be easier and more flexible with dosing, possibly 3 times weekly.
> Degludec will also have a u-200 version which allows more insulin in a
> reduced
> volume for those who require large amounts. DegludecPlus has a fixed dose 
> of
> mealtime and basal insulin-70%-Degludec-basal and 30%-Novolog-mealtime.
> Novo-Nordisk
> is filing for FDA approval for this new insulin in January, 2012.
> 3. DPP4-inhibitors - Januvia, Onglyza, and Tradjenta. These three already
> FDA approved oral, once daily, medications help the pancreas secrete 
> insulin
> when
> the blood sugars are high as in post-prandial [after a meal] so that blood
> sugar spikes are not so dramatic and also lowers the risk of hypoglycemia.
> They
> reduce glucagon production from the liver, decrease gastric emptying as 
> well
> as increase satiation. They are only approved for type 2 diabetes. They 
> work
> by allowing GLP1, a gut hormone, to stay in the body longer which improves
> control of sugar as well as reducing your appetite. They are available in
> combination
> pills with Metformin - called Janumet and Kombiglyze. The side effects are
> minimal and can include symptoms of a cold, headache, nausea as well as 
> mild
> skin reactions. These medications are more expensive compared to the older
> diabetes oral medications.
> 4. Tandem Diabetes Care - T: slim. A new insulin pump, approved by the FDA
> which should be available by early 2012. It is slimmer, roughly the size 
> of
> a
> deck of cards, has a 300 unit reservoir which can connect to any 
> commercial
> infusion set with luer connections such as the Comfort, Quick-set, Inset, 
> or
> Cleo. It has a rechargeable battery, is compatible with Macs or PCs, has a
> color touch screen, has USB connectivity, is easy to use and uses
> micro-delivery
> technology which equates to higher accuracy. The negative is that it is 
> not
> water-proof. The screen should have a protective cover, like an iPhone. It
> is only approved for people over 12 years old but studies are being done 
> on
> children under the age of 12.
> list end
>
>
> Doug and Weaver
> natemaster at atmc.net
>
>
>


--------------------------------------------------------------------------------


> _______________________________________________
> Diabetes-talk mailing list
> Diabetes-talk at nfbnet.org
> http://nfbnet.org/mailman/listinfo/diabetes-talk_nfbnet.org
> To unsubscribe, change your list options or get your account info for 
> Diabetes-talk:
> http://nfbnet.org/mailman/options/diabetes-talk_nfbnet.org/bandbjacobs%40verizon.net
>